Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1484 of 5804
-
Transplant vs. standard care: which protects sickle cell Kids' brains better Long-Term?
Knowledge-focused CompletedThe purpose of the present observational study is to remotely reevaluate the cohort of 67 sickle cell patients with transcranial Doppler-detected cerebral vasculopathy included in the national "Sickle Cell Transplant" protocol and whose 1- and 3-year results were published in JAM…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Virus-Enhanced cocktail shows promise in stubborn myeloma
Disease control OngoingThis phase I/II trial studies the safety of the combination of bortezomib, dexamethasone, and pembrolizumab with or without pelareorep in treating patients with multiple myeloma that has come back (relapsed) or does not response to treatment (refractory). Chemotherapy drugs, such…
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a cheap supplement cut deaths from alcoholic hepatitis?
Disease control Recruiting nowThis study is designed to evaluate the hypothesis that patients with severe acute alcoholic hepatitis have lower morbi-mortality if the patients receive treatment with corticosteroids + NAC, compared to patients that only receive corticosteroids.
Phase: NA • Sponsor: Bioaraba Health Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug combo aims to stop head and neck cancer relapse in High-Risk patients
Disease control TerminatedThe purpose of this study is to demonstrate the superior efficacy of Xevinapant (Debio 1143) versus placebo when added to radiotherapy in the treatment of high-risk participants with resected locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) who are ineligi…
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Radiation boost may help CAR t therapy work better for tough lymphomas
Disease control OngoingThe purpose of this study is to test whether radiation therapy given before standard CAR T cell therapy is a safe and effective treatment for people with relapsed and refractory B cell lymphoma. The researchers will also study whether radiation therapy used in this study is a pra…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill AND019 takes on tough breast cancer in first human test
Disease control Recruiting nowThis is a first in human dose escalation and expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) activity, and preliminary anti-tumor activity of AND019 in postmenopausal women with advanced or metastatic estrogen receptor (ER)-positiv…
Phase: PHASE1 • Sponsor: Kind Pharmaceuticals LLC • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New vaccine aims to shield against multiple coronaviruses at once
⭐️ VACCINE ⭐️ CompletedVBI-2901a is an investigational vaccine candidate that uses enveloped virus-like particles (eVLPs) to express the spike proteins of three coronaviruses: SARS-CoV-2 (the virus that causes COVID-19 disease), SARS-CoV-1 and MERS-CoV. The trivalent vaccine candidate is designed to in…
Phase: PHASE1 • Sponsor: VBI Vaccines Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
New catheter aims to drain fluid in stubborn heart failure cases
Disease control OngoingThe study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.
Phase: NA • Sponsor: Revamp Medical Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Lab-Grown lung tumors could personalize cancer care
Knowledge-focused OngoingExtra tissue will be taken from patient during a procedure in standard of care. Also, through an existing line, 10ml of extra blood will be drawn. From this material the investigator will try to establish matched normal and primary human lung cancer organoids.
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Brain gene therapy tested for Parkinson's – early results in
Disease control CompletedThe objective of this clinical trial was to evaluate the safety and tolerability of adeno-associated virus (AAV)-mediated delivery of glutamic acid decarboxylase (GAD) gene transfer into the subthalamic nuclei (STN) of participants with Parkinson's Disease.
Phase: PHASE1, PHASE2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Jun 26, 2026 14:07 UTC
-
New combo therapy targets Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of neratinib in combination with trastuzumab deruxtecan in treating patients with solid tumors that have spread from where it first started (primary site) to other places in the body (metastatic) or that cannot be r…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug cocktail shows promise for Hard-to-Treat bone marrow cancer
Disease control OngoingThe purpose of this study is to find out whether combination treatment with the study drugs belantamab mafodotin, nirogacestat, and pomalidomide is a safe treatment for people who have relapsed or refractory multiple myeloma. The researchers will test different doses of belantama…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Robotic glove aims to restore hand movement for spinal cord injury patients
Symptom relief Recruiting nowThe purpose of this study is to develop and test the hardware and software components of the MyHand-SCI device to assist with hand function for individuals with C6-C7 spinal cord injury.
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Digital screening may boost HIV prevention in Women's health visits
Prevention OngoingHybrid Type II effectiveness-implementation trial to investigate whether electronic medical and sexual history data collection with HIV risk categorization/scoring will increase pre-exposure prophylaxis (PrEP) uptake among cis-gender women attending routine well-woman gynecologic…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 08:14 UTC
-
Heart-Device study aims to stop strokes in patients with a hole in the heart
Disease control OngoingThe purpose of this post-marketing surveillance is to evaluate the effectiveness and safety of GORE® CARDIOFORM Septal Occluder under the post-marketing setting in Japan.
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Wireless bladder sensor could help veterans regain control
Disease control Recruiting nowIncontinence associates with military service and post-traumatic stress disorder in both male and female Veterans. Neurogenic detrusor overactivity (NDO) is caused by spinal cord injury or disorder, or peripheral neurodegenerative conditions, and causes urine leakage at low volum…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Brain training after ICU: hope for dementia-like fog?
Disease control OngoingMillions of patients survive care in medical and surgical Intensive Care Units (ICUs) every year, only to suffer from a new or accelerated dementia-like process, called post-ICU long-term cognitive impairment (ICU-LTCI). ICU-LTCI causes considerable problems with personal relatio…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Robotic exosuit boosts walking for spinal injury patients
Symptom relief CompletedThe Myosuit is a light-weighted lower extremity soft exosuit which provide assistance during walking. In this study the Myosuit will be tested in the home and community setting in patients with incomplete spinal cord injury.
Phase: NA • Sponsor: Sint Maartenskliniek • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Knee pain showdown: which injection works best for osteoarthritis?
Symptom relief CompletedThe clinical trial will be carried out at the Dr. Moh. Hoesin Central Hospital, Palembang and planned from October 2022 to March 2023. This study aims to compare the efficacy of Platelet Rich Plasma, Conditioned Medium From Umbilical Cord Mesenchymal Stem Cell (MSC) Culture Secr…
Phase: PHASE1, PHASE2 • Sponsor: Universitas Sriwijaya • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Education program aims to cut stroke recurrence in bangladesh
Disease control Recruiting nowStroke is a major public issue that can be occurred a patient with severe and unbearable disability for a long time. Recurrence of stroke is increasing due to a lack of knowledge and compliance with treatment regarding the modifiable risk factors of stroke and behavioral and life…
Phase: NA • Sponsor: Hiroshima University • Aim: Disease control
Last updated Jun 26, 2026 17:05 UTC